Subclinical inflammation in AT is systemic in morbid obesity, which can be confirmed by positive associations of the plasma level of chemerin with CRP in patients with T2DM (r = 0.76, p < 0.01) (Fig. 1d). This evidence concerns the gene CRP and morbid obesity.